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Abstract: Churg Strauss Syndrome (CSS) is an autoimmune condition that causes inflammation of small and medium-
sized blood vessels. It is a non-infectious systemic vasculitis, which affects mainly the lungs but also other tissues and 
organs. CSS is considered a highly variable condition in terms of its presentation and its course. The most serious 
complication of the vasculitic stage is congestive heart failure with reduced ejection fraction. We present a case with first 
diagnosed heart failure because of CSS and review of the literature. 
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CASE PRESENTATION 
A 50-year-old female was admitted to the 
emergency department of our hospital with symptoms 
of dyspnoea on exertion, retrosternal burning pain, 
numbness of upper and lower limbs and inability to 
walk. The patient presents with worsening dyspnoea on 
exertion the last ten days and retrosternal pain within 
24 hours.  
She has been hospitalized to pulmonary clinic 
twenty days ago and left with a diagnosis of 
postinfectious bronchial asthma for which has been 
treated with corticosteroids and antibiotics. Three 
weeks later she presented numbness of lower limbs, 
muscular weakness, burning pain in ankle joints and 
Purpura type rash in the legs. Medical history was 
positive for arterial hypertension on treatment 
(carvedilol, valsartan and hydrochlorothiazide), 
smoking and presence of thyroid nodules. Family 
history of asthma and brother with sudden cardiac 
death are also referred.  
The physical examination revealed blood 
pressure:135/85 mmHg, respiratory rate: 16 / min, 
temperature: 36.7 °C, pulse: 111 / min, S1, S2 distinct 
and rhythmic, systolic murmur heard over tricuspid and 
mitral valve area, distended jugular veins, mild oedema 
and numbness of lower limbs , diffuse rhonchi bilateral 
with reduction in the bases, liver painless and slightly 
palpable, spleen impalpable, reduction in muscle 
strength of lowering limbs, left foot drop, maculopapular 
rash on the lower limbs in resolution. Physical 
examination of other systems was normal. 
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The admission ECG showed sinus tachycardia (111 
/ min), poor deployment of R in V1-V3 leads, negative 
T waves in II, III, aVf, V3-V6 leads, PR: 160 
msec,QRS: 80 msec, QTc: 420 msec (Figure 1). 
 
Figure 1:  
The chest x-ray showed bilateral distension of 
pulmonary portals (Figure 2). 
Laboratory tests showed elevated troponin (2457 
ng/mL) and elevated level of eosinophil count in the 
peripheral blood (WBC: 14.72/µL, NEU/LYM: 
36,8/12,6, EOS 48%, RBC: 3,94/Μl, HCT: 36, Hb: 12,4 
g/dL, MCV: 91,6 fL, PLTs: 316/µL). 
Echocardiography revealed left ventricle with End 
Diastolic Diameter 56 mm and normal wall thickness 
but systolic dysfunction (Ejection Fraction 35%) with 
hypokinesia of anterior interventricular diaphragm - 
anterior and lateral wall. There was also mild to 
moderate mitral and tricuspid regurgitation (PASP 
40mmHg) and mild pericardial effusion (maximum 
14mm next to right atrium) (Figures 3, 4). 
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The patient initially hospitalized in Cardiology clinic 
due to elevated cardiac enzyme (troponin: 2457 ng/mL) 
where treated with the recommended medical 
treatment such as b-blocker, angiotensin II receptor 
blocker, furosemide, aspirin, spironolactone and statin. 
There was not conducted urgent coronary angiography 
because of the presence of fever, and the HCG 
alterations had no change. The angiographic study 
which was performed later did not show any stenosis of 
the coronary arteries.  
The patient was transferred to the Internal Medicine 
clinic in order to be further searched for his anemia, 
eosinophilia, neuropathy and asthma. Serological 
markers of HBV, HCV, HIV, Aspergillus, Echinococcus 




Figure 3:  
 
Figure 4: 
18    International Journal of Cardiology and Lipidology Research, 2015, Vol. 2, No. 2 Lampropoulos et al. 
function tests were normal (Τ3:102, FT4:1.3, TSH :0.1, 
Anti TPO:18.8, Anti Tg:13.8). Electrophoresis of serum 
proteins showed mild decrease of albumin and higher 
levels of alpha globulins (Albumin: 45.9, Alpha1: 10.3, 
Alpha2:15.4, Beta:11.1, Gamma:17.3). From tumor 
markers only Cancer Antigen 125 was elevated (CEA: 
1.07, AFP: 1.49, CA 15-3:8.2, CA-125: 64.6, CA19-
9:13.13). From the rest immunological control higher 
level of Immunoglobulin E and Rheumatoid Factor 
arised (IgG: 1150, IgA: 82.2, IgM:84.8, IgE:514, 
Rheumatoid Factor:22, C3:158,C4:48.4). Plasma 
autoantibodies (Abs) were negative except from 
perinuclear anti-neutrophil antibodies (p-ANCA, titres 
1:160). 
Moreover, we proceeded to detection of fusion gene 
BCR / ABL in peripheral blood [1] and dedection of 
FIP1L1-PDGFRa fusion gene [2] in bone marrow 
smear which are associated with Chronic Myelogenous 
Leukemia (CML) and Hypereosinophilic Syndrome 
(HES), respectively. 
Bone marrow biopsy was negative and skin-muscle 
biopsy was not diagnostic. 
The Electromyography highlighted sensorimotor 
neuropathy predominant in lower limbs. Body 
Computed Tomography revealed hemangioma in 
thoracic vertebra and fibrous elements in the anterior 
base of the right and the left lung. 
Because of the presence of p-ANCA antibodies, 
peripheral neuropathy and eosinophilia, the patient 
considered that he was suffering from Churg Strauss 
Syndrome (CSS) and treated with prezolon 75 mg and 
medrol 32 mg per day. The treatment for heart failure 
which was mentioned above continued plus inhaled 
corticosteroids due to symptoms and findings from the 
respiratory. After regression of eosinophilia and 
dyspnea she was transferred to the Rheumatology 
Clinic where she underwent biopsy of left leg nerve and 
nasal mucosal. Both biopsies were negative. In a new 
echocardiography study after treatment we found 
improvement of left ventricle systolic function with mild 
hypokinesia of anterior apical interventricular septum. 
The Ejection Fraction was calculated at 50% with 
Simpson’s method. Pericardial fluid was absent (Figure 
5). 
The patient exited on medical treatment with 
methylprednisolone 16 mg, calcium, alendronate 70 
mg, atorvastatin 40 mg, metoprolol 100 mg, valsartan 
40 mg, aspirin 100 mg and omeprazole 20 mg. 
DISCUSSION 
In our case differential diagnosis should be 
performed between Churg Strauss Syndrome (CSS), 
Wegener's granulomatosis, Idiopathic 
Hypereosinophilia Syndrome, Loeffler Syndrome, 
Kounis Syndrome, Eosinophilic Leukemia, Takotsubo 
cardiomyopathy and Ischemic Heart Disease.  
CSS [3-5] (also known as eosinophilic 
granulomatosis with polyangiitis or allergic 
granulomatosis) is an autoimmune condition that 
causes inflammation of small and medium-sized blood 
vessels (vasculitis) in persons with a history of airway 
allergic hypersensitivity (atopy). It is a non-infectious 
systemic vasculitis, which affects mainly the lungs but 
also other tissues and organs. It constitutes 2% of all 
vasculitis. In asthmatic patients, the frequency of CSS 
 
Figure 5:  
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estimated at 34.6 / 1 million people – years. CSS is 
slightly more common in males, at a ratio of 1.4 / 1 and 
is usually seen in people aged 15-69 years. The 
manifestations of vasculitis usually appear in the 
middle of the 4th decade of life. CSS is associated with 
various endogenous or exogenous factors: heredity, 
parasitic diseases, drugs (carbamazepine, macrolides) 
and environmental factors.  
CSS consists of three stages, but not all patients 
develop all three stages or progress from one stage to 
the next in the same order. The early (prodromal) stage 
is marked by airway inflammation. Almost all patients 
experience mild to severe asthma and/or allergic 
rhinitis, nasal polyposis, sinusitis and recurrent 
bronchitis or pneumonitis. It lasts average 28 months 
(range 4-72 months) and in some patients 30 years. 
The second stage is characterized by abnormally high 
numbers of eosinophils (hypereosinophilia) in 
peripheral blood, in combination with tissue 
eosinophilia and Loeffler's syndrome and fever (in 
exacerbations of the disease). The symptoms of 
hypereosinophilia depend on which part of the body is 
affected, but most often it affects the lungs and 
digestive tract. The eosinophilic stage can last months 
or years, and its symptoms can disappear, only to 
return later. Patients may experience the third stage 
simultaneously. The third stage consists of vasculitis, 
which can eventually lead to cell death and can be life-
threatening. It manifests with congestive heart failure, 
bloody diarrhea (usually due to mesenteric vasculitis), 
abdominal pain, pain in the testicles, peripheral 
neuropathy (usually multiple mononeuritis), 
convulsions, mental and motor disorders, usually 
sudden. Often affected the sciatic and, less frequently, 
the radial, the means and the ulnar nerve. Clinical 
examination shows motor and sensory (hypesthesia or 
hyperesthesia, allodynia, pain) disorders, particularly of 
the lower extremities. Frequent skin lesions are 
purpura and nodules. 
CSS is consequently considered a highly variable 
condition in terms of its presentation and its course. 
The most serious complication of the vasculitic stage is 
congestive heart failure with reduced ejection fraction 
(85% of cases) and vasculitis coronary artery 
granulomatous pericarditis (about 1/3 of the patients). 
Kidney complications have been reported as being less 
common. 
Eosinophilia (>1.500/mm3 or >10% of peripheral 
white blood cells) is typical finding of CSS in the 
second phase in 90% of untreated patients and remits 
immediately with corticosteroids. There are also 
observed increased acute phase proteins (ESR, CRP), 
normocytic anemia, increased titles of ANCA, mainly p-
ANCA and increase in serum IgE. 
For classification purposes, a patient shall be said 
to have CSS if at least four of these six criteria are 
positive: Asthma, Eosinophils greater than 10% of a 
differential white blood cell count, Presence of 
mononeuropathy or polyneuropathy, Unfixed 
pulmonary infiltrates, Presence of paranasal sinus 
abnormalities, Histological evidence of extravascular 
eosinophils.  
Treatment for CSS includes glucocorticoids (such 
as prednisolone). The corticosteroids are the main 
treatment for CSS. Other immunosuppressive drugs 
(such as azathioprine, methotrexate, cyclosporine 
cyclophosphamide) consists second line treatment 
when it is indicated (severe manifestations of the 
disease or non-response/complications in corticoste- 
roids). Interferon-a and plasmapheresis can be used as 
3rd line. Over 90% of patients with CSS have remission 
with corticosteroids, although 25-30% of them relapse. 
Corticosteroids also improves systolic and diastolic 
dysfunction of the heart associated with 
cardiomyopathy. Greater risk of death or serious 
morbidity are patients with severe myocardial or 
gastrointestinal vasculitis. The 5-year survival of CSS is 
62%. 
In our case the obtained biopsies were negative for 
vasculitis. However due to the presence of positive p-
ANCA antibodies, peripheral neuropathy and 
eosinophilia, the patient considered that he was 
suffering from CSS and treated with prezolon 75 mg 
and medrol 32 mg per day. The patient exited on 
medical treatment with methylprednisolone 16 mg, 
calcium, alendronate 70 mg, atorvastatin 40 mg, 
metoprolol 100 mg, valsartan 40 mg, aspirin 100 mg 
and omeprazole 20 mg. 
Idiopathic Hypereosinophilia Syndrome [6, 7] is 
characterized by eosinophilia and anemia. In our 
patient, it has been excluded since we did not dedect 
FIP1L1-PDGFRa fusion gene in bone marrow smear 
which is associated with. Löffler's syndrome [8] is a 
disease in which eosinophils accumulate in the lung or 
in the heart in response to a parasitic infection (Ascaris 
lumbricoides mainly). [9] Löffler's endocarditis can be 
presented with restrictive cardiomyopathy due to 
infiltration of the endocardium by eosinophils or 
myocardial fibrosis and thrombi in the cavities of the 
heart. It progresses rapidly to death. Control for 
paracite infection was negative in our case. Kounis 
20    International Journal of Cardiology and Lipidology Research, 2015, Vol. 2, No. 2 Lampropoulos et al. 
syndrome [10, 11] is a group of symptoms that 
manifests as acute coronary syndrome and is triggered 
by the release of inflammatory mediators following an 
allergic insult and causes coronary artery spasm and/or 
atheromatous plaque erosion or rupture. It is also 
characterized by eosinophilia and IgE (+). 
Wegener's granulomatosis (WG) [12, 13] is a form 
of vasculitis that affects small size vessels in many 
organs. Damage to the lungs and kidneys by an 
autoimmune attack of cytoplasmic antineutrophil 
antibodies(c-ANCAs) can be fatal.  
The generalized WG is characterized by necrotizing 
granulomatous vasculitis of the upper or lower 
respiratory tract (paranasal sinuses, nasal passages, 
throat, lungs), generalized necrotizing vasculitis of 
arteries and veins and focal necrotizing 
glomerulonephritis. Limited WG affects the upper 
respiratory or lungs. 
Autoimmune or allergic reactions or hypersensitivity 
reactions to unknown antigens such as bacterias. The 
most common micro-organism which is involved 
considered Staphylococcus aureus. WG may be silent 
or may have a rapidly progressive course. 
It may be manifest as myocarditis, endocarditis, 
myocardial ischemia due to coronary vasculitis or 
complete atrioventricular block. Heart failure may be 
the first manifestation of the disease. Pericarditis is the 
most common heart attack event in WG, observed in 
50% of cases of histologically established infection of 
the heart. Diagnosis of WG is based on a combination 
of clinical manifestations and laboratory findings 
(anemia, thrombocytosis, eosinophilia, hypergamma- 
globulinemia, increase ESR and CRP, proteinuria, 
microscopic hematuria, c-ANCAs), and if necessary, 
histological findings (granulomatous inflammation 
involving the respiratory tract and of small vessels). 
Diagnosis requires the presence 2/4 criteria. The 
presence of any 2 or more criteria has sensitivity 82.2% 
and specificity of 92%. Corticosteroids and 
cyclophosphamide are the recommended treatment 
[14]. 
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